-
The end of the national talks: the negotiation of exclusive varieties of proprietary Chinese medicines is easy PD-1 finale
Time of Update: 2023-02-01
On January 8, the four-day 2022 national health insurance negotiations came to an end. The representatives of the companies present today are still waiting for a number of blockbuster new drugs in th
-
The reform of DRG's payment method "traditional Chinese medicine" has achieved new results
Time of Update: 2023-01-06
As of the end of October 2022, a total of 1,829 designated medical institutions in 15 coordinated areas in Guangxi have implemented DRG payment, covering 87.
As of the end of October 2022, a total of 1,829 designated medical institutions in 15 coordinated areas in Guangxi have implemented DRG payment, covering 87.
-
The reform of DRG's payment method "traditional Chinese medicine" has achieved new results
Time of Update: 2023-01-06
As of the end of October 2022, a total of 1,829 designated medical institutions in 15 coordinated areas in Guangxi have implemented DRG payment, covering 87.
As of the end of October 2022, a total of 1,829 designated medical institutions in 15 coordinated areas in Guangxi have implemented DRG payment, covering 87.
-
Shanghai copper weak bottoming operation pay attention to the support around 68,000
Time of Update: 2022-12-23
During the day, Shanghai copper bottoming out was mainly stable, approaching the eleventh long holiday spot trading willingness decreased, technically Shanghai copper affected by the US index breakthrough possibility decreased, transformed into a range shock weak bottoming pattern.
-
September 2017 cable raw materials (rubber) monthly report
Time of Update: 2022-12-07
2. The number of initial jobless claims in the United States in the week of September 16 was 259,000, expected to be 302,000, and the previous value of 284,000 was revised to 282,000.
-
Shanghai copper fluctuated at a high level, and the rise was slightly weak
Time of Update: 2022-12-07
During the day, the Shanghai copper 1712 contract fell slightly to 54890 yuan / ton under pressure, indicating that the upper selling pressure was heavier, and after the short-term copper price continued to rise, it faced technical pullback pressure, and bulls lacked the willingness to further rise before the strengthening of the dollar and China's third-quarter GDP and other heavy data were not released.
-
In 2019, China is expected to complete and operate offshore floating nuclear power plants
Time of Update: 2022-11-20
Recently, the National Development and Reform Commission officially replied to the letter and agreed that the offshore floating nuclear power plant ACP100S declared by CNNC was included in the 13th Five-Year Plan for energy innovation.
-
Power equipment standards are not in line with international standards, hindering the pace of going to sea
Time of Update: 2022-11-18
Recently, Zheng Jianjiang, deputy to the National People's Congress and chairman of Oaks Group, said that some national standards for China's power equipment are still not in line with relevant international standards, hindering the pace of China's equipment manufacturing enterprises to expand overseas markets.
-
The chemical raw material and product manufacturing capacity utilization rate in the second quarter was 77.7
Time of Update: 2022-11-04
6 percentage points over the same period of the previous year; the capacity utilization rate of the manufacturing industry was 75.
6 percentage points over the same period of the previous year; the capacity utilization rate of the manufacturing industry was 75.
-
Two departments: relying on the emergency general hospital to establish a national pneumoconiosis diagnosis and treatment center
Time of Update: 2022-10-01
Hospitals According to the website of the Ministry of Emergency Management, the Ministry of Emergency Management recently issued a notice on the establishment of a national pneumoconiosis diagnosis and treatment center, and the National Health Commission agreed to rely on the emergency general hospital to establish a national pneumoconiosis diagnosis and treatment center.
-
Joint Prevention and Control Mechanism of the State Council: The recent spread of the epidemic has coexisted from "things to people" and "from people to people
Time of Update: 2022-09-05
Source: China Youth Daily This newspaper, Beijing, November 25 (China Youth Daily, China Youth Daily reporter Zhang Manyu) "In the past 30 days, China has added 98 new local confirmed cases, which is 7.
-
The TDI tar recovery particle bed dryer jointly developed by Wanhua Chemical and Tianhua Research Institute was successfully tested
Time of Update: 2022-08-29
The picture shows the test separation of TDI productsThis time, Tianhua Institute cooperated with Wanhua Chemical, a leading TDI enterprise, relying on the National Drying and Equipment Engineering Technology Research Center of Tianhua Institute to jointly promote the research and development of TD tar recovery particle bed dryer .
-
Build a display platform to present the four new achievements of the industry, lead the development of the industry to meet the needs of a better life "2020 China International
Time of Update: 2022-05-29
On the afternoon of October 10, 2020, the "2020 China International Plastics Exhibition and the 4th Plastic New Materials, New Technologies, New Equipment, and New Products Exhibition" (abbreviated as: 2020 China International Plastics Exhibition) press conference was held at Nanjing International Expo Held in the center .
-
Multiple domestic new crown drugs entering clinical trials are expected to become anti-epidemic weapons
Time of Update: 2021-12-01
State Council From the hundreds of antibodies isolated from the blood of convalescent patients, 2 strains of antibodies with high activity and strong complementarity were screened-the new coronavirus antibody combination drug BRII developed by Tsinghua University, Shenzhen Third People's Hospital and Tengsheng Biopharmaceutical team -196/BRII-198, has recently completed the foreign phase III clinical trials, and has been urgently called by the relevant departments to provide clinical treatment for more than 800 cases of infection in China .
-
Because of the azithromycin tablets in the prescription, the doctors and pharmacists "fight
Time of Update: 2021-10-02
In 2021, The New England Journal of Medicine published a randomized, double-blind, controlled clinical trial aimed at comparing the efficacy of single-dose azithromycin and doxycycline 7-day therapy in the treatment of men with male-to-male chlamydia infection.
